Emerging Therapies for Lung Cancer

30. 9. 2009 - 30. 9. 2009, Morton’s The Steakhouse, San Francisco, California, USA


Odborný program

6:15 pm
Welcome and introduction


7:00 pm
Maintenance/consolidation therapy for advanced NSCLC: Are there new standards of care?

7:25 pm
Can clinical markers, histology and molecular markers guide our management strategies for NSCLC: What do recent clinical trial results demonstrate?

7:40 pm
Targeting EGFR and VEGF/VEGFR in NSCLC: Choosing the best targeted agents to combine with chemotherapy using clinical and biologic prognostic factors

8:05 pm
Emerging targets and therapeutic agents for NSCLC: m-TOR inhibitors, c-met inhibitors, IGF1R inhibitors, HSP90 inhibitors, Src inhibitors and others

8:30 pm
Panel discussion

9:00 pm

Web: http://www.emergin...r.com/sanfran.html

  • Sdílejte na:
    • Facebook
    • Twitter
    • Del.icio.us
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live